Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 5.33 years. directly owns 3.19% of the company’s shares, worth $7.47M. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.
Key information
Craig Mull
Chief executive officer
US$1.0m
Total compensation
CEO salary percentage
n/a
CEO tenure
5.3yrs
CEO ownership
3.2%
Management average tenure
2.5yrs
Board average tenure
3.5yrs
Recent management updates
Recent updates
CEO
Craig Mull
5.3yrs
Tenure
US$1,045,700
Compensation
Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Craig Mull
Interim CEO & Chairman of the Board
5.3yrs
US$1.05m
3.19% $ 7.5m
Bryan Jacobs
Chief Financial Officer
2.3yrs
US$391.35k
0.020% $ 45.7k
Emilio Presti
Director of Sales & Marketing
2.8yrs
no data
no data
Hamed Ghanei
Chief Business Officer
less than a year
no data
no data
2.5yrs
Average Tenure
Experienced Management: CPHR.F's management team is considered experienced (2.5 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Craig Mull
Interim CEO & Chairman of the Board
5.7yrs
US$1.05m
3.19% $ 7.5m
Harold Wolkin
Lead Independent Director
8.3yrs
US$73.49k
1.43% $ 3.4m
Douglas Deeth
Independent Director
1.4yrs
US$65.57k
no data
Hubert Walinski
Independent Director
1.4yrs
US$62.57k
no data
3.5yrs
Average Tenure
Experienced Board: CPHR.F's board of directors are considered experienced (3.5 years average tenure).